News

Viking Therapeutics Options Activity: A Deep Dive Analysis

Viking Therapeutics Options Activity: A Deep Dive Analysis

Understanding Recent Options Trends for Viking Therapeutics

Whales, or large investors, are increasingly showing confidence in Viking Therapeutics. This prominent biotech company's options history reflects a growing bullish expectation among traders.

Upon reviewing the options activity for Viking Therapeutics (VKTX), there were 14 recorded trades. Among these, a significant 71% of investors acted with bullish intentions, while only 21% were bearish.

Breaking down the trades, we see four puts valued at $146,590 and an impressive ten calls totaling nearly $1.7 million. This highlights a substantial inclination towards expecting positive stock movement.

Price Target Insights

Recent analyses indicate that key players are targeting a price range of $35.00 to $100.00 for Viking Therapeutics over the last quarter. This window suggests a strong belief in the potential for significant growth.

Examining Volume and Open Interest

Volume and open interest are crucial metrics for options traders. They provide insights into the liquidity and overall interest levels at various strike prices. The data from Viking Therapeutics indicates a robust trading environment, suggesting high engagement from market participants.

Viking Therapeutics Call and Put Volume: Recent Overview

Below is an overview of notable options trades within the recent month for Viking Therapeutics:

Significant Options Activity

Some remarkable trades include:

  • One call trade at a strike price of $90.00, with a total trade price of $1.0M, showcased bearish sentiment, expiring in January 2025.
  • A call with a bullish sentiment showed strong interest, particularly a sweep trade for $10.2 at a $60.00 strike price, indicating solid market confidence.
  • Another sweep trade occurring in December 2024, displaying bullish indicators, indicates a further optimistic outlook for Viking Therapeutics.

About Viking Therapeutics

Viking Therapeutics Inc focuses on biopharmaceutical development mainly related to metabolic and endocrine disorders. Its clinical pipeline includes promising products like VK2809, VK5211, and VK0214. The former two are selective agonists of the thyroid hormone receptor beta, while VK5211 acts as a selective androgen receptor modulator.

Current Position of Viking Therapeutics

  • Viking Therapeutics is experiencing a trading volume of over a million shares, currently priced at $62.15, down by 3.4%.
  • The Relative Strength Index (RSI) reflects a neutral position, indicating the stock is neither overbought nor oversold.
  • An earnings announcement is eagerly awaited, adding to market speculation.

Analyst Insights on Viking Therapeutics

Recently, analysts have expressed varied opinions on VKTX. Two experts have rated the stock, with an average target price suggesting room for growth, estimated at $114.00. A notable downgrade from Oppenheimer has brought the target price to $138, while HC Wainwright & Co. has set a target of $90.

The Stakes with Options Trading

Engaging with options trading carries inherent risks compared to stock trading. However, with greater risk comes a higher potential for profit. Experienced traders understand the importance of constant learning and monitoring the market to effectively manage their investments.

If you want to keep up with the latest developments in options trading for Viking Therapeutics, staying updated is key.

Frequently Asked Questions

What is Viking Therapeutics known for?

Viking Therapeutics is recognized for developing treatments targeting metabolic and endocrine disorders, utilizing innovative drug therapies.

Why are investors showing bullish sentiment in VKTX?

The bullish sentiment arises from recent trades indicating strong interest and expectations of significant stock price increases.

What are options in stock trading?

Options are financial instruments that give investors the right, but not the obligation, to buy or sell a stock at a predetermined price before a specified expiration date.

What role does volume play in options trading?

Volume indicates the number of contracts traded, which helps investors gauge market activity and potential liquidity for specific options.

Can I stay informed about Viking Therapeutics options activity?

Yes, you can stay updated by following market reports, newsletters, or investment platforms providing real-time trading alerts.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Natus Medical Enhances InVisus Pro NMUS Integration features

Updated Category News Views 157

Natus Medical's New Integration for Enhanced User Experience Natus Medical Incorporated has recently introduced a noteworthy development within its product line. The integration of the InVisus Pro Neuromuscular Ultrasound system with Natus Elite Software is a significant enhancement for EMG system users. This innovation enables a seamless connection between the InVisus...

Continue Reading
Innovative Uber Campaign by It's a 10® Haircare Captivates Consumers

Updated Category News Views 240

It’s a 10® Haircare Unveils Dynamic Advertising Strategy It's a 10® Haircare, a renowned professional haircare brand, has taken an exciting leap into innovative advertising with their recent Uber campaign. This unique initiative not only elevates the brand's visibility but also connects directly with beauty enthusiasts who frequent major retail outlets. Engaging...

Continue Reading
Essential Update on Cohen & Steers Quality Income Realty Fund

Updated Category News Views 85

Cohen & Steers Quality Income Realty Fund Overview In this article, we dive into the details regarding the distribution sources for Cohen & Steers Quality Income Realty Fund, Inc. (RQI). This information is crucial for current shareholders as it directly impacts their investment decisions and overall understanding of the fund's financial performance. Understanding Managed...

Continue Reading
Maggie Q's ActivatedYou Morning Complete Reaches Milestone Sales

Updated Category News Views 402

Understanding the Success of ActivatedYou Morning Complete Maggie Q's ActivatedYou has recently celebrated a remarkable achievement, hitting over 5 million units sold of their flagship product, Morning Complete. This milestone is a testament to the product's appeal and the effectiveness that many consumers have experienced. What is ActivatedYou Morning Complete? Morning...

Continue Reading
New Stad Center Aims to Transform Pediatric Pain Management

Updated Category News Views 360

Transforming Pediatric Pain Management with Integrative Approaches The Stad Center for Pediatric Pain, Palliative and Integrative Medicine at UCSF Benioff Children's Hospitals has recently launched a groundbreaking facility. This innovative center blends Eastern and Western medicine to provide a comprehensive care approach for children experiencing pain and serious...

Continue Reading